NCT07277270 2026-01-07A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid TumorsGlaxoSmithKlinePhase 1 Recruiting84 enrolled
NCT05914116 2025-11-21A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid TumorsDualityBio Inc.Phase 1/2 Recruiting862 enrolled
NCT05057013 2025-08-11A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid TumoursCancer Research UKPhase 1/2 Active not recruiting81 enrolled
NCT03685591 2024-06-26PF-06952229 Treatment in Adult Patients With Advanced Solid TumorsPfizerPhase 1 Terminated49 enrolled 33 charts
NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT02138383 2021-08-17Enzalutamide in Combination With Gemcitabine and Nab-Paclitaxel for the Treatment of Advanced Pancreatic CancerH. Lee Moffitt Cancer Center and Research InstitutePhase 1 Completed25 enrolled
NCT02642913 2021-03-05Study of Enzalutamide With and Without Sorafenib in Advanced Hepatocellular Carcinoma PatientsMemorial Sloan Kettering Cancer CenterPhase 1 Completed28 enrolled